🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Current dosing regimens for vancomycin result in many young infants not rea...
Status
Completed
Location
Royal Hospital for Women
Start Date
2019-08-30
Trial ID
NCT04044703
Treatments Being Tested
This is a randomized, controlled multicenter clinical trial. The purpose of...
Status
Unknown
Location
Faculty of Medicine University os São Paulo
Start Date
2018-04-28
Trial ID
NCT03438214
Treatments Being Tested
The objectives of this study is to exploratory whether Vancomycin + Delpazo...
Status
Terminated
Location
Chosun University Hospital
Start Date
2022-04-26
Trial ID
NCT05225558
Treatments Being Tested
Babies aged 0 to 90 days with a suspected infection requiring treatment wit...
Status
Completed
Location
Royal Hospital for Women
Start Date
2014-09
Trial ID
NCT02210169
Treatments Being Tested
Evaluate the safety and outcomes associated between the two treatment modal...
Status
Terminated
Location
Wake Forest Health Sciences
Start Date
2021-03-03
Trial ID
NCT04648696
Treatments Being Tested
Hospitalized patients with suspected or confirmed infection are commonly tr...
Status
Recruiting
Location
University of Pennsylvania Health System
Start Date
2026-01-28
Trial ID
NCT06954129
Treatments Being Tested
Vancomycin is an essential antimicrobial which is frequently used in the IC...
Status
Terminated
Location
MGH
Start Date
2013-09
Trial ID
NCT01786161
Treatments Being Tested
This study is being carried out to find out whether there is reduction in v...
Status
Unknown
Location
National University Hospital
Start Date
2012-10
Trial ID
NCT01720940
Treatments Being Tested
Hospitalized adult participants prescribed vancomycin by their treating phy...
Status
Completed
Location
University of Kentucky
Start Date
2023-05-22
Trial ID
NCT05823116
Treatments Being Tested